Hey Freak, ( Good name for you) If you feel that way you should sell now, wait, you don't like this stock, so #$%$? Y R U Hear? PS, Looks like your working overtime
If CVM pops he's in trouble. He's shorting to accumulate shares on the cheap. If you sell, he benefits. Check the short volume for the past 5 days. He's responsible for all of it.
Max's note, now owned by a Trust that Geert is a beneficiary of, has been extendded by two years. In return for this generous action, the Trust gets a slew of new in-the-money stock options!
Way to look out for the average shareholder! LOL!
I am out of this stock, but wonder why you make such a comment with nothing to even account for your words. Why do you think anyone would waste time even reading this. Would Like to hear what you have to say.
"At 25 new patients enrolled per month"
Hey Freaky ole Freak, I guess I missed it?
Where in the PR did it say that, going forward, Cel-Sci will ALWAYS have 25 patients per month?
Spin Away, Baby! LOL
I don't care if you lose everything. But then I think that most of those who pump this awful POS don't really own any shares, they just flip them into the pumps.
Keep it coming. Best case for you is Phase III fails and this stock is done. Assuming you are short 100,000 shares, you stand to gain $70,000 as of now. Great for you. However, just knowing that any moment this stock could get "halted" on positive news, takeover, results, etc. and then re-open at $2 or $5 or $10...Wow, I am glad I don't have to live with that stress every night of a potential "endless" amount of loss! That is way more scary then waiting for a potential new treatment for Cancer! Good luck.
Sentiment: Strong Buy
Hey Freak, Your spending a lot of time trying to HElp, Warn, Caution, US???, But you don't get it, NO One cares what you have to say, It is so obvious that you have your own agenda. TATA shorty,
Flaherty is just another penny stock pimp, along the lines of Dirks, di Stefano, etc., that Geert hires to promote his POS company. Notice that Flaherty simply apes Geert's claims and nbever does analyse the pitfully small amount of data there are on Multikine, which if he really did do so he'd find to be a complete farce!
Geert pays to promote it because he has no real news or data to deliver.
No question there'll be more dilution.With or without delays. I don't think anyone here denies that, even the most fervent cheerleaders.
The question is, at what price to shareholders.
At $2, no one here will care. At $.050, almost everyone will.
Time equates to delay and delay equates to more money which equates to additional dilution. So no, this is not good.
You really need new material. Does your husband ever get tired of you whining? LOL! Yes, only daytraders follow this Magna Cum Laude graduate of Harvard award-winning retired Senior Editor of Forbes Magazine. He wrote 33 cover stories, two shy of the all-time Forbes record.
Sentiment: Strong Buy
Um, can you remember all the way back to Monday? You know, when the paid penny stock pump piece was issued to stir up some of the more ignorant day trader types?
The only ones who own CVM are those too ignorant to understand what a comnplete joke the existing Multikine data are. 19 patients in total in the 'survival' calculation, 2 who did not even have head and neck cancer, compared to historical survival rates reported in the literature going back to the 1980s! Astoundingly stupid!
By the way, 5-year survival in the early 2000s was reported as 66% so all of those who accept Geert's farcical 47.5% 3 year survival as the hurdle are going to get a very rude shock when the Multikine PhIII data are reported (that is, if they ever are released)!